- Home
- NFBK vs BME Comparison
NFBK vs BME Comparison
Compare NFBK & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NFBK | BME |
|---|---|---|
| Founded | 1887 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.2M | 536.7M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | NFBK | BME |
|---|---|---|
| Price | $12.26 | $40.46 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 229.9K | 34.0K |
| Earning Date | 01-21-2026 | 01-01-0001 |
| Dividend Yield | 4.24% | ★ 6.26% |
| EPS Growth | ★ 51.92 | N/A |
| EPS | 0.97 | ★ 1.44 |
| Revenue | ★ $141,983,000.00 | N/A |
| Revenue This Year | $9.42 | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | ★ $12.60 | $28.37 |
| Revenue Growth | ★ 13.99 | N/A |
| 52 Week Low | $9.40 | $35.53 |
| 52 Week High | $13.26 | $43.20 |
Technical Indicators
Market Signals| Indicator | NFBK | BME |
|---|---|---|
| Relative Strength Index (RSI) | 73.74 | 57.05 |
| Support Level | $11.17 | $39.81 |
| Resistance Level | $12.36 | $40.67 |
| Average True Range (ATR) | 0.32 | 0.42 |
| MACD | 0.16 | -0.16 |
| Stochastic Oscillator | 96.04 | 38.22 |
Price Performance
Historical ComparisonAbout NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.